Improving Guideline-Based PrEP Management in a Philadelphia-Based Academic Family Medicine Office

Presenter Information

Brittany MacDonald, MD, Thomas Jefferson UniversityFollow
Marshall Miller, MD, Thomas Jefferson UniversityFollow
Nwando Ekezie, MD, Thomas Jefferson UniversityFollow
Maia Mandel, MD, Thomas Jefferson UniversityFollow
Christina Boras, MD, Thomas Jefferson UniversityFollow
Eunice Choe, MD, Thomas Jefferson UniversityFollow
Meghan Swyryn, MD, Thomas Jefferson UniversityFollow
Meg Broderick, MD, Thomas Jefferson UniversityFollow
Pascaline Karanja, MD, Thomas Jefferson UniversityFollow
Julia Beatini, MD, Thomas Jefferson UniversityFollow
Julie Jones, Thomas Jefferson University

Start Date

5-15-2025 9:30 AM

End Date

5-15-2025 11:30 AM

Description

Background

Pre-Exposure Prophylaxis (PrEP) significantly reduces the risk of contracting HIV:

• Reduces risk from sexual contact by 99%
• Reduces risk from injection drug use by at least 74%

Despite its effectiveness, PrEP is underutilized in the USA.

• In 2019, an estimated 224,000 Americans received a prescription for PrEP despite 1.1 million people having indications for PrEP.
• Lack of provider knowledge surrounding PrEP clinical guidelines is a common reason for underutilization.

Keywords

HIV, PrEP, infectious disease, sexual health

Comments

Presented at the 2025 Jefferson Health Equity and Quality Improvement (HEQI) Summit.